Skip to main content
Watch Insiders
LPCNHealthcare

Lipocine Inc (LPCN) Insider Trading

In the last 90 days, 1 Lipocine Inc (LPCN) insider reported 2 open-market purchases totaling $82,175 and no sales. The most recent open-market purchase was reported on Sep 30, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$82,175
Corporate buyers
1
Latest transaction
Sep 30, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 30, 2026John W. HiguchiCorporate insiderOpen Market Purchase25,007$2.20$55,043
Sep 28, 2026John W. HiguchiCorporate insiderOpen Market Purchase12,561$2.16$27,132

Common questions

LPCN insider trading FAQ

Are LPCN insiders buying or selling?
Over the last 90 days, LPCN insiders were net buyers, reporting $82,175 of open-market purchases and $0.00 of sales.
When was the last LPCN insider purchase?
The most recent open-market purchase of Lipocine Inc stock by an insider was reported on Sep 30, 2026, one of 2 purchases in the last 90 days.
Where does LPCN insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Lipocine Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.